Citation Impact
Citing Papers
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Efficacy, Safety, and Effects on Quality of Life of Salmeterol Versus Albuterol in Patients with Mild to Moderate Persistent Asthma
1998
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
1998
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma
2004
Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis
2014
Budesonide and Formoterol in a Single Inhaler Improves Asthma Control Compared With Increasing the Dose of Corticosteroid in Adults With Mild-to-Moderate Asthma
2003
Safety of formoterol by Turbuhaler® as reliever medication compared with terbutaline in moderate asthma
2002
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy
2001
Dietary Intake of Soy Genistein is Associated with Lung Function in Patients with Asthma
2004
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
2003
Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)
2000
Inhaled Glucocorticoids for Asthma
1995
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patients
1996
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
1999
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
β-Adrenergic Bronchodilators
1995
Long-Acting β2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells
2007
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial
2004
Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators
1998
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Development and validation of a questionnaire to measure asthma control
1999 Standout
Asthma
2017 Standout
When can personal best peak flow be determined for asthma action plans?
2004
Impact of preventing exacerbations on deterioration of health status in COPD
2004 Standout
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
2003
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
2003
Long-Acting β<SUB>2</SUB>-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Long-acting ?2-agonists in management of childhood asthma: A critical review of the literature
2000
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
2007
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
2005
A tutorial on pilot studies: the what, why and how
2010 Standout
Asthma
2001 Standout
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
2009 Standout
Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma
1997
Advair: Combination treatment with fluticasone propionate/salmeterol in the treatment of asthma
2001
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study
2006
A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma
2006
Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids
2002
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma
2003
Asthma exacerbations {middle dot} 4: Prevention
2006
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma
1997
A Comparison of the Validity of Different Diagnostic Tests in Adults With Asthma
2002
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
2002 Standout
Interactions between commensal intestinal bacteria and the immune system
2004 Standout
Inhaled Corticosteroid Reduction and Elimination in Patients With Persistent Asthma Receiving Salmeterol<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?
1997
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Asthma
2000 Standout
Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids
2000
Safety and Efficacy of Fluticasone and Beclomethasone in Moderate to Severe Asthma
1998
Combination Therapy with a Long-Acting β-Agonist and a Leukotriene Antagonist in Moderate Asthma
2006
Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma
1999
Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics
1998
A Long-term Study of the Antiinflammatory Effect of Low-dose Budesonide Plus Formoterol versus High-dose Budesonide in Asthma
2000
Asthma
2005
Addition of Salmeterol versus Doubling the Dose of Beclomethasone in Children with Asthma
1998
Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma
1999
Choosing a Long-term Controller Medication in Childhood Asthma
1997
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist
2002
Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
2001
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patients
1996
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
2003
Guidelines for management of asthma at primary and secondary levels of health care in India (2005).
2005
Long- and Short-Acting ß2-Adrenergic Agonists
1996
Canadian Asthma Consensus Conference Summary of Recommendations
1996
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
2000
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
The impact of training informal health care providers in India: A randomized controlled trial
2016 StandoutScienceNobel
Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators
1997
Works of G.M. Shaw being referenced
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
1994